EPCR Antibody (LMR-42) is a rat monoclonal IgG2a antibody that detects EPCR in mouse, rat, and human samples through immunofluorescence (IF) and flow cytometry (FCM) applications. Anti-EPCR antibody (LMR-42) is available in a non-conjugated form, allowing for versatile experimental setups. The endothelial Protein C receptor (EPCR) plays a crucial role in the regulation of coagulation and inflammation by facilitating the activation of Protein C, which is essential for maintaining hemostatic balance. Located predominantly on the surface of endothelial cells in large blood vessels, particularly in the heart and lungs, EPCR enhances the anticoagulant pathway initiated by the TM/Thrombin complex. This complex is vital for converting Protein C into its activated form, which subsequently inactivates key clotting factors, thereby preventing excessive thrombin formation and promoting vascular health. EPCR expression is not only significant for anticoagulant properties but also for involvement in inflammatory responses, as EPCR can modulate the interaction between coagulation and inflammation. Additionally, the EPCR gene is located on human chromosome 20q11.2, and EPCR protein structure reveals homology to the major histocompatibility complex, indicating evolutionary importance and potential implications in immune responses. Understanding EPCR function and location is essential for developing therapeutic strategies targeting coagulation disorders and inflammatory diseases.
Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA
LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
EPCR Antibody (LMR-42) | sc-57106 | 500 µl supernatant | $322.00 |